Revel Pharmaceuticals Inc. — Form D

Revel Pharmaceuticals Inc. of San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-03-23. The offering totals $5.8M, of which $5.8M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2022-03-23
• Form: D
• Accession: 0001800934-22-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $5.8M
• Amount sold: $5.8M
• Investors: 3
• Date of first sale: 2022-02-23
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-438594

Issuer

• Name: Revel Pharmaceuticals Inc.
• CIK: 0001800934
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2019
• Address: 2325 3rd Street, San Francisco, CA, 94107
• Phone: (217) 766-4292

Officers, directors & promoters (6)

Other filings by this issuer (2)

More

• CIK 1800934 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search